Drugs / Liu Wei Di Huang Pill
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT05125081 | Jan 2022 → Aug 2024 | presbycusis | Shanghai Jiao Tong University School of Medicine | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT05001217 | Jan 2022 → Dec 2023 | Parkinson disease | Hong Kong Baptist University | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05266079 | Mar 2022 → Jun 2023 | — | Hong Kong Baptist University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liu Wei Di Huang Pill | “4. Kidney Yin Deficiency Syndrome use Liu Wei Di Huang Pill and Er Zhi Pill(LWDHP and EZP) ;” NCT05266079 ↗ |
| Known as | LWDHP | “4. Kidney Yin Deficiency Syndrome use Liu Wei Di Huang Pill and Er Zhi Pill(LWDHP and EZP) ;” NCT05266079 ↗ |